RPRX News 15.98 Repros Therapeutics Inc (RPRX)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Repros Therapeutics Inc (RPRX) 15.98 $RPRX

Repros Completes Enrollment for Androxal Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 5:15PM CDT
Repros Therapeutics announced it has completed enrollment for one of the two head-to-head studies on its secondary hypogonadism candidate, Androxal.

Repros Fully Enrolls First of Two Previously Announced Head to Head Studies of Androxal(R) Versus the Leading Topical Testosterone Gel
GlobeNewswire - Mon Apr 14, 9:34AM CDT
-- Company expects topline results by October 2014

Repros Provides Proellex Update - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 18, 4:10PM CDT
Repros Therapeutics announced that it has received guidance from the FDA related to Proellex.

Repros Allowed to Conduct Phase 1 and 2 Clinical Studies of Low Dose Oral Proellex(R) in the Treatment of Uterine Fibroids and Endometriosis
GlobeNewswire - Mon Mar 17, 8:20AM CDT
Repros Therapeutics Inc.(Nasdaq:RPRX) today reported it has received guidance from the FDA indicating that Repros may proceed to conduct Phase 1 and 2 studies of oral Proellex under two separate INDs for endometriosis and uterine fibroids, while remaining on partial clinical hold. The FDA guidance provides that the highest allowed dose will be 12 mg daily. Repros is currently conducting a Phase 2 study for the use of Proellex in severe endometriosis and plans to submit a Phase 2 protocol for the treatment of symptomatic fibroids.

Narrower-than-Expected Q4 Loss at Repros - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 8:50AM CDT
Repros fourth quarter 2013 loss of 31 cents per share was narrower than the year-ago loss of 47 cents.

Repros Therapeutics Inc.(R) Reports Fourth Quarter and Year End 2013 Financial Results
GlobeNewswire - Thu Mar 13, 8:15AM CDT
Repros Therapeutics Inc. (Nasdaq:RPRX) today announced financial results for the fourth quarter and year ended December 31, 2013.

Bullish Two Hundred Day Moving Average Cross - RPRX
MarketNewsVideo.com - Tue Feb 18, 3:38PM CST
In trading on Tuesday, shares of Repros Therapeutics Inc crossed above their 200 day moving average of $19.54, changing hands as high as $19.87 per share. Repros Therapeutics Inc shares are currently trading up about 6% on the day.

Data on Repros' Androxal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 5:26PM CST
Repros Therapeutics recently released additional results from its phase III study, ZA-300, on candidate Androxal.

Repros Therapeutics (RPRX) Jumps: Stock Rises 6.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 8:46AM CST
Repros Therapeutics was a big mover last session, with shares rising over 6%.

Repros Reports Findings From the Six Month Study of Androxal(R) in Men With Secondary Hypogonadism
GlobeNewswire - Mon Feb 10, 8:39AM CST
-- Greater Than 80% of Men Obtained T in the Normal Range

This Week in Biotech: Sunny, With No Chance of Rain
Sean Williams, The Motley Fool - Motley Fool - Sat Feb 08, 1:05PM CST
With the  SPDR S&P Biotech Index  up 57% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and companies...

Repros Shares Soar After FDA Meeting - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 07, 9:27AM CST
Share price of Repros surged 15.8% after its meeting with the FDA on Androxal

Biotech Winners: Pernix, Myriad, Repros, OraSure
David Williamson and Max Macaluso, The Motley Fool - Motley Fool - Thu Feb 06, 7:40PM CST
In this video from Thursday's Market Checkup , Motley Fool health-care analysts David Williamson and Max Macaluso dive into the biggest stories impacting health-care investors on the market today. In this segment, a look at some big winners during...

Nasdaq stocks posting largest percentage increases
AP - Thu Feb 06, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:

Why Repros Therapeutics, Inc. Shares Soared
Sean Williams, The Motley Fool - Motley Fool - Thu Feb 06, 2:11PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Repros Therapeutics , a clinical-stage...

Repros Therapeutics rises on Androxal update
AP - Thu Feb 06, 10:35AM CST
NEW YORK (AP) — Shares of Repros Therapeutics jumped Thursday after the company said it doesn't think it will have to run additional safety studies of its testosterone drug Androxal.

Repros Meets With FDA to Discuss Data Requirements for Androxal(R) in the Treatment of Secondary Hypogonadism
GlobeNewswire - Wed Feb 05, 11:22PM CST
-- NDA submission remains anticipated by year end 2014

Analysis of the Southeast Asian Manufacturing Execution Systems Market
PR Newswire - Thu Jan 30, 6:14AM CST
Reportlinker.com announces that a new market research report is available in its catalogue:
Scroll down for more posts ▼

Top 10 Most Recent News Articles

J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 77

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Pigeon Unveils Green Innovations at CIIE 2026

Updated Category News Views 174

An International Celebration: Cultural Connections at CIIE Babies have a way of bringing the world together. Every culture has its own quirks and traditions, but the love for a newborn is common ground. Pigeon gets that, and they're putting it on full display at the China International Import Expo (CIIE) in Shanghai. It's their fourth run at this rodeo, and they’re not...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 34

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 108

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
Key Players Depart No Makeup Makeup Amid Rapid Success

Updated Category News Views 214

Change is afoot in the world of beauty. No Makeup Makeup, a brand that's managed to carve out a sizable niche, recently bid farewell to two of its main architects: Kim Wileman and Shauna Lahiri. These women didn't just steer the ship; they built the damn thing. Kicking Off the No Makeup Revolution Wileman and Lahiri were the pistons firing away at No Makeup Makeup, a...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 117

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
AXON Revenue Forecast Cut Spurs Legal Investigation

Updated Category News Views 135

Axon's Revenue Forecast Takes a Hit Listen up, folks. Axon Enterprise, Inc. (NASDAQ: AXON) has stirred the pot, cutting their 2026 revenue forecast faster than you can say "counter-drone deployment." Back in August, they were riding high on their second-quarter call, raising their growth forecast to a cheerful 32%-34%. Fast forward to November, and it's been slashed to...

Continue Reading
Pinterest Faces Legal Probe: Investor Concerns Rise

Updated Category News Views 95

Legal Storms Gather on Pinterest's Horizon I remember a time when Pinterest was the darling of Wall Street, but here we are, staring at an investigation that's got more layers than an onion. On November 6, 2026, news broke that Kahn Swick & Foti, LLC (KSF) is sniffing around Pinterest's officers and directors. This is no small fry since KSF is steered by none other than...

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 88

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading
Sensitron's 270VDC SSPCs: A Power System Shake-Up

Updated Category News Views 148

Revolutionizing Power Distribution with Sensitron Some days, the tech world dishes out real game-changers, and looks like November 6, 2026, was one of those days. Sensitron Semiconductor dropped a bombshell with their SPHM/SEHM Series—a brand-new lineup of programmable 16-channel Solid State Power Controllers (SSPCs). Tailored for the grueling demands of 270VDC power...

Continue Reading

Top 5 Most Recently Viewed Articles

Significant Advances in Heart Failure Treatment with Aquadex

Updated Category News Views 106

Promising Findings in Heart Failure Management Nuwellis, Inc. has made headway in the treatment of heart failure, showcasing new insights on the effectiveness of the Aquadex SmartFlow ultrafiltration therapy. Recent analysis suggests significant advantages over traditional diuretic therapies, particularly in reducing heart failure events. Insights from the AVOID-HF Study...

Continue Reading
Unity Software's Market Dynamics: Understanding Short Interest Trends

Updated Category News Views 444

Unity Software's Recent Short Interest Trends Unity Software's short percent of float has seen a noticeable increase of 10.37% since the last report. Currently, the data indicates that there are 32.52 million shares sold short, which constitutes 8.09% of the total shares available for trading. Given the current trading volume, it would require approximately 3.36 days on...

Continue Reading
Monaco Classic Week: A Celebration of Vessels and Cinema

Updated Category News Views 154

Monaco Classic Week: A Nautical Extravaganza Each September, the picturesque Principality of Monaco transforms into a maritime paradise, welcoming sea lovers and yachting enthusiasts alike. This year, the vibrant event known as Monaco Classic Week celebrates its 17th edition, showcasing a remarkable fleet of around 160 vessels. Spearheaded by the renowned Yacht Club de...

Continue Reading
Innovation in Property Management: Insights from AppFolio

Updated Category News Views 206

Innovation in Property Management: Insights from AppFolio AppFolio (NASDAQ: APPF), a frontrunner in real estate technology, has recently released their 2024 Property Manager Renter Preferences Report. This report offers crucial insights for property managers who are looking to adapt to the changing expectations of today’s renters. Based on a survey of over 2,000 U.S....

Continue Reading
FG Nexus Inc. Transforms with $200M Private Placement Success

Updated Category News Views 601

FG Nexus Inc. Secures $200 Million for Ethereum Strategy Net Proceeds Will Immediately Fund Ethereum (ETH) Acquisition Maja Vujinovic at the Helm of Digital Asset Operations Company Set to Rebrand as FG Nexus Inc. Charlotte, NC - Fundamental Global Inc. (NASDAQ: FGF, FGFPP), soon known as FG Nexus Inc. with its ticker symbols changing to FGNX and FGNXP, has announced the...

Continue Reading